These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 39159267)

  • 1. A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy.
    Krishnan N; Priestman M; Uhía I; Charitakis N; Glegola-Madejska IT; Baer TM; Tranberg A; Faraj A; Simonsson US; Robertson BD
    PLoS Biol; 2024 Aug; 22(8):e3002766. PubMed ID: 39159267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
    Minassian AM; Satti I; Poulton ID; Meyer J; Hill AV; McShane H
    J Infect Dis; 2012 Apr; 205(7):1035-42. PubMed ID: 22396610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and vaccine potential of clinical isolate
    Kim H; Shin SJ
    Microbiol Spectr; 2024 Aug; 12(8):e0081924. PubMed ID: 38980025
    [No Abstract]   [Full Text] [Related]  

  • 6. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
    Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
    PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
    Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
    PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8
    Moliva JI; Hossfeld AP; Canan CH; Dwivedi V; Wewers MD; Beamer G; Turner J; Torrelles JB
    Mucosal Immunol; 2018 May; 11(3):968-978. PubMed ID: 28930287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
    Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
    Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host and pathogen genetic diversity shape vaccine-mediated protection to
    Cohen SB; Plumlee CR; Engels L; Mai D; Murray TA; Jahn AN; Alexander B; Delahaye JL; Cross LM; Maciag K; Schrader S; Durga K; Gold ES; Aderem A; Gerner MY; Gern BH; Diercks AH; Urdahl KB
    Front Immunol; 2024; 15():1427846. PubMed ID: 39007152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.
    Minhinnick A; Harris S; Wilkie M; Peter J; Stockdale L; Manjaly-Thomas ZR; Vermaak S; Satti I; Moss P; McShane H
    J Infect Dis; 2016 Mar; 213(5):824-30. PubMed ID: 26450421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques.
    Tsujimura Y; Shiogama Y; Soma S; Okamura T; Takano J; Urano E; Murakata Y; Kawano A; Yamakawa N; Asaka MN; Matsuo K; Yasutomi Y
    J Immunol; 2020 Dec; 205(11):3023-3036. PubMed ID: 33097574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.
    Oliveira FM; Trentini MM; Junqueira-Kipnis AP; Kipnis A
    Mem Inst Oswaldo Cruz; 2016 Apr; 111(4):223-31. PubMed ID: 27074251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.
    Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M
    Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
    Marcus SA; Steinberg H; Talaat AM
    Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
    Minassian AM; Ronan EO; Poyntz H; Hill AV; McShane H
    PLoS One; 2011; 6(5):e19840. PubMed ID: 21629699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.